(S)-2-(4'-tert-butylbiphenyl-2-ylcarboxamido)-N-(2-(4-fluorobenzylamino)-2-oxo-1-phenylethyl)quinoline-6-carboxamide

ID: ALA2147297

Chembl Id: CHEMBL2147297

PubChem CID: 15603841

Max Phase: Preclinical

Molecular Formula: C42H37FN4O3

Molecular Weight: 664.78

Molecule Type: Small molecule

Associated Items:

Names and Identifiers

Canonical SMILES:  CC(C)(C)c1ccc(-c2ccccc2C(=O)Nc2ccc3cc(C(=O)N[C@H](C(=O)NCc4ccc(F)cc4)c4ccccc4)ccc3n2)cc1

Standard InChI:  InChI=1S/C42H37FN4O3/c1-42(2,3)32-19-15-28(16-20-32)34-11-7-8-12-35(34)40(49)46-37-24-18-30-25-31(17-23-36(30)45-37)39(48)47-38(29-9-5-4-6-10-29)41(50)44-26-27-13-21-33(43)22-14-27/h4-25,38H,26H2,1-3H3,(H,44,50)(H,47,48)(H,45,46,49)/t38-/m0/s1

Standard InChI Key:  PKHKBSZSOWOOPU-LHEWISCISA-N

Associated Targets(Human)

MTTP Tclin Microsomal triglyceride transfer protein large subunit (242 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 664.78Molecular Weight (Monoisotopic): 664.2850AlogP: 8.38#Rotatable Bonds: 9
Polar Surface Area: 100.19Molecular Species: NEUTRALHBA: 4HBD: 3
#RO5 Violations: 2HBA (Lipinski): 7HBD (Lipinski): 3#RO5 Violations (Lipinski): 2
CX Acidic pKa: 13.66CX Basic pKa: 1.68CX LogP: 8.78CX LogD: 8.78
Aromatic Rings: 6Heavy Atoms: 50QED Weighted: 0.14Np Likeness Score: -1.31

References

1. Robinson RP, Bartlett JA, Bertinato P, Bessire AJ, Cosgrove J, Foley PM, Manion TB, Minich ML, Ramos B, Reese MR, Schmahai TJ, Swick AG, Tess DA, Vaz A, Wolford A..  (2011)  Discovery of microsomal triglyceride transfer protein (MTP) inhibitors with potential for decreased active metabolite load compared to dirlotapide.,  21  (14): [PMID:21684740] [10.1016/j.bmcl.2011.05.099]

Source